
Solutions for
Individual Subjects
Axcelead offers the optimum solution in line with your research theme
Click here for detailsAxcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan, having inherited the unique and comprehensive capabilities of drug discovery from Takeda Pharmaceutical Company Limited: “Experienced Scientists”, “Cutting-edge Technology Platform”, and “Huge Historical Drug Discovery Data”, and started its business in 2017.
Axcelead offers the optimum solution in line with your research theme
Click here for detailsAxcelead offers fully integrated drug discovery services from target discovery to IND enabling translational research
Click Here for DetailsThe new modalities support epoch-making discovery research including breakthroughs in regenerative medicine, nucleic acids and peptide drug discovery
Click Here for DetailsOur highly experienced and expert staff will take care of your non-clinical development strategy and work to solve any problems
Click Here for DetailsHuman genome KI mice and rats is useful for the evaluation of new modality and small molecule in cases where efficacy has not been demonstrated on any other species.
DetailsAimed at bio-venture capitalists, academia, and companies planning to enter the pharmaceutical industry who wish to out-license
Click Here for DetailsDiscovery On Target 2023: Meet us in Boston
Axcelead DDP’s Drug Discovery Support Business Honored with the 6th Japan Medical Research and Development Grand Prize
Discussions Begin on Collaborative Genomic Drug Discovery Support Using the IQVIA Genome Wide Study Platform
HTS is a service to identify hit compounds with high probability in a short period of time.
We enable improvement of drug development efficiency and seamless translational research!
We offer an optimal package service for you to achieve your goal, such as IND application and out-licensing
Check out our latest scientific research, insights and passion for drug discovery.
We enjoy the patronage of more than 100 facilities, including pharmaceutical companies, startups and academic institutions